Quick Answer
Medicale Corp. reported Diluted EPS of $0.01 per share (loss) for fiscal year 2025.
Medicale Corp. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.01 | +0.0% |
| 2024 | -$0.01 | +0.0% |
| 2023 | -$0.01 | +0.0% |
| 2022 | -$0.01 | +0.0% |
| 2021 | -$0.01 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $0.00 | — | — |
| June 30, 2025 | $0.00 | — | — |
| March 31, 2025 | $0.00 | — | — |
| December 31, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | — | — |
| March 31, 2024 | $0.00 | — | — |
| December 31, 2023 | $0.00 | — | — |
| June 30, 2022 | $0.00 | — | — |
- Medicale Corp. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Medicale Corp.’s diluted eps has grown by 0.0% (from $0.01 per share (loss) to $0.01 per share (loss)).
- The most recent figure is from Medicale Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: